Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Prevention of otitis media by vaccination.
Russell, F; MULHOLLAND, K;
2002
Drugs, (2002).62 10 10.2165/00003495-200262100-00002.
Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.
Mwinga, A; Nunn, A; Ngwira, B; Chintu, C; Warndorff, D; FINE, P; Darbyshire, J; Zumla, A; LUSKAR collaboration,;
2002
Lancet, (2002).360 9339 10.1016/S0140-6736(02)11141-X.
Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine.
Obaro, SK; Enwere, GC; Deloria, M; Jaffar, S; Goldblatt, D; Brainsby, K; Hallander, H; McInnes, P; GREENWOOD, BM; McAdam, KP W J;
2002
The Pediatric infectious disease journal, (2002).21 10 10.1097/00006454-200210000-00011.
Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomized community trial to evaluate the impact on tuberculosis of BCG revaccination at school age.
Barreto, ML; RODRIGUES, LC; Cunha, SS; Pereira, S; Hijjar, MA; Ichihara, MY; De Brito, SC; Dourado, I;
2002
Controlled clinical trials, (2002).23 5 10.1016/s0197-2456(02)00216-7.
L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlations with larval output.
Atkins, NS; CONWAY, DJ; Lindo, JF; Bailey, JW; BUNDY, DA;
2002
Parasite immunology, (2002).21 10 10.1046/j.1365-3024.1999.00248.x.
The average cost of measles cases and adverse events following vaccination in industrialised countries.
Carabin, H; EDMUNDS, WJ; Kou, U; Van den Hof, S; Nguyen, VH;
2002
BMC public health, (2002).2 1 10.1186/1471-2458-2-22.
Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guérin vaccination in northern Malawi.
FLOYD, S; Pönnighaus, JM; Bliss, L; Nkhosa, P; Sichali, L; Msiska, G; FINE, PE M;
2002
The Journal of infectious diseases, (2002).186 6 10.1086/342416.
Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis.
ACHARYA, A; Diaz-Ortega, JL; Tambini, G; De Quadros, C; Arita, I;
2002
Vaccine, (2002).20 27-28 10.1016/s0264-410x(02)00296-7.
Varicella vaccination: a double-edged sword?.
EDMUNDS, WJ; Brisson, M; Gay, NJ; MILLER, E;
2002
Communicable disease and public health / PHLS, (2002).5 3
Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.
THOMAS, SL; Wheeler, JG; Hall, AJ;
2002
Lancet, (2002).360 9334 10.1016/S0140-6736(02)09837-9.